Companies House 2025-04-01 2026-03-31 2026-03-31 false true iso4217:GBP xbrli:pure NI056317 2024-04-01 2025-03-31 NI056317 2026-03-31 NI056317 2025-04-01 2026-03-31 NI056317 2025-03-31 NI056317 curr:PoundSterling 2025-04-01 2026-03-31 NI056317 uk-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 NI056317 uk-bus:FRS102 2025-04-01 2026-03-31 NI056317 uk-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 NI056317 uk-bus:AbridgedAccounts 2025-04-01 2026-03-31 NI056317 uk-bus:RegisteredOffice 2025-04-01 2026-03-31 NI056317 uk-bus:Director40 2025-04-01 2026-03-31 NI056317 uk-bus:Director1 2025-04-01 2026-03-31 NI056317 uk-bus:Director2 2025-04-01 2026-03-31 NI056317 uk-bus:Director3 2025-04-01 2026-03-31 NI056317 uk-bus:Director4 2025-04-01 2026-03-31 NI056317 uk-bus:Director5 2025-04-01 2026-03-31 NI056317 uk-bus:Director6 2025-04-01 2026-03-31 NI056317 uk-bus:Director7 2025-04-01 2026-03-31 NI056317 uk-bus:Director8 2025-04-01 2026-03-31 NI056317 uk-bus:Director9 2025-04-01 2026-03-31 NI056317 uk-bus:Director10 2025-04-01 2026-03-31 NI056317 uk-bus:Director11 2025-04-01 2026-03-31 NI056317 uk-bus:Director12 2025-04-01 2026-03-31 NI056317 uk-bus:Director13 2025-04-01 2026-03-31 NI056317 uk-bus:Director14 2025-04-01 2026-03-31 NI056317 uk-bus:Director15 2025-04-01 2026-03-31 NI056317 uk-bus:Director16 2025-04-01 2026-03-31 NI056317 uk-bus:Director17 2025-04-01 2026-03-31 NI056317 uk-bus:Director18 2025-04-01 2026-03-31 NI056317 uk-bus:Director19 2025-04-01 2026-03-31 NI056317 uk-bus:Director20 2025-04-01 2026-03-31 NI056317 uk-bus:CompanySecretary1 2025-04-01 2026-03-31 NI056317 core:AfterOneYear 2026-03-31 NI056317 core:AfterOneYear 2025-03-31 NI056317 core:WithinOneYear 2026-03-31 NI056317 core:WithinOneYear 2025-03-31 NI056317 core:WithinOneYear 2025-04-01 2026-03-31 NI056317 core:AfterOneYear 2026-03-31 NI056317 core:AfterOneYear 2025-03-31 NI056317 core:AfterOneYear 2025-04-01 2026-03-31 NI056317 core:ShareCapital 2026-03-31 NI056317 core:ShareCapital 2025-03-31 NI056317 core:SharePremium 2026-03-31 NI056317 core:SharePremium 2025-03-31 NI056317 core:OtherReservesSubtotal 2026-03-31 NI056317 core:OtherReservesSubtotal 2025-03-31 NI056317 core:RevaluationReserve 2026-03-31 NI056317 core:RevaluationReserve 2025-03-31 NI056317 core:RetainedEarningsAccumulatedLosses 2026-03-31 NI056317 core:RetainedEarningsAccumulatedLosses 2025-03-31 NI056317 core:Associate1 2025-04-01 2026-03-31 NI056317 core:Associate1 2025-03-31 NI056317 core:Associate1 2026-03-31 NI056317 core:Associate2 2025-04-01 2026-03-31 NI056317 core:Associate2 2025-03-31 NI056317 core:Associate2 2026-03-31 NI056317 core:Associate3 2025-04-01 2026-03-31 NI056317 core:Associate3 2025-03-31 NI056317 core:Associate3 2026-03-31 NI056317 core:Associate4 2025-04-01 2026-03-31 NI056317 core:Associate4 2025-03-31 NI056317 core:Associate4 2026-03-31 NI056317 core:Associate5 2025-04-01 2026-03-31 NI056317 core:Associate5 2025-03-31 NI056317 core:Associate5 2026-03-31 NI056317 core:Associate6 2025-04-01 2026-03-31 NI056317 core:Associate6 2025-03-31 NI056317 core:Associate6 2026-03-31 NI056317 core:Associate7 2025-04-01 2026-03-31 NI056317 core:Associate7 2025-03-31 NI056317 core:Associate7 2026-03-31 NI056317 core:Associate8 2025-04-01 2026-03-31 NI056317 core:Associate8 2025-03-31 NI056317 core:Associate8 2026-03-31 NI056317 core:Associate9 2025-04-01 2026-03-31 NI056317 core:Associate9 2025-03-31 NI056317 core:Associate9 2026-03-31 NI056317 core:Associate10 2025-04-01 2026-03-31 NI056317 core:Associate10 2025-03-31 NI056317 core:Associate10 2026-03-31 NI056317 core:Associate11 2025-04-01 2026-03-31 NI056317 core:Associate11 2025-03-31 NI056317 core:Associate11 2026-03-31 NI056317 core:Associate12 2025-04-01 2026-03-31 NI056317 core:Associate12 2025-03-31 NI056317 core:Associate12 2026-03-31 NI056317 core:Associate13 2025-04-01 2026-03-31 NI056317 core:Associate13 2025-03-31 NI056317 core:Associate13 2026-03-31 NI056317 core:Associate14 2025-04-01 2026-03-31 NI056317 core:Associate14 2025-03-31 NI056317 core:Associate14 2026-03-31 NI056317 core:Associate15 2025-04-01 2026-03-31 NI056317 core:Associate15 2025-03-31 NI056317 core:Associate15 2026-03-31 NI056317 core:Associate16 2025-04-01 2026-03-31 NI056317 core:Associate16 2025-03-31 NI056317 core:Associate16 2026-03-31 NI056317 core:Associate17 2025-04-01 2026-03-31 NI056317 core:Associate17 2025-03-31 NI056317 core:Associate17 2026-03-31 NI056317 core:Associate18 2025-04-01 2026-03-31 NI056317 core:Associate18 2025-03-31 NI056317 core:Associate18 2026-03-31 NI056317 core:Associate19 2025-04-01 2026-03-31 NI056317 core:Associate19 2025-03-31 NI056317 core:Associate19 2026-03-31 NI056317 core:Associate20 2025-04-01 2026-03-31 NI056317 core:Associate20 2025-03-31 NI056317 core:Associate20 2026-03-31 NI056317 core:Associate1 2025-04-01 2026-03-31 NI056317 core:Associate2 2025-04-01 2026-03-31 NI056317 core:Associate3 2025-04-01 2026-03-31 NI056317 core:Associate4 2025-04-01 2026-03-31 NI056317 core:Associate5 2025-04-01 2026-03-31 NI056317 core:Associate6 2025-04-01 2026-03-31 NI056317 core:Associate7 2025-04-01 2026-03-31 NI056317 core:Associate8 2025-04-01 2026-03-31 NI056317 core:Associate9 2025-04-01 2026-03-31 NI056317 core:Associate10 2025-04-01 2026-03-31 NI056317 core:Associate11 2025-04-01 2026-03-31 NI056317 core:Associate12 2025-04-01 2026-03-31 NI056317 core:Associate13 2025-04-01 2026-03-31 NI056317 core:Associate14 2025-04-01 2026-03-31 NI056317 core:Associate15 2025-04-01 2026-03-31 NI056317 core:Associate16 2025-04-01 2026-03-31 NI056317 core:Associate17 2025-04-01 2026-03-31 NI056317 core:Associate18 2025-04-01 2026-03-31 NI056317 core:Associate19 2025-04-01 2026-03-31 NI056317 core:Associate20 2025-04-01 2026-03-31 NI056317 uk-bus:Director1 1 2025-04-01 2026-03-31 NI056317 uk-bus:Director1 1 2025-03-31 NI056317 uk-bus:Director1 1 2026-03-31 NI056317 uk-bus:Director2 2 2025-04-01 2026-03-31 NI056317 uk-bus:Director2 2 2025-03-31 NI056317 uk-bus:Director2 2 2026-03-31 NI056317 uk-bus:Director1 3 2025-04-01 2026-03-31 NI056317 uk-bus:Director1 3 2025-03-31 NI056317 uk-bus:Director1 3 2026-03-31 NI056317 uk-bus:Director4 4 2025-04-01 2026-03-31 NI056317 uk-bus:Director4 4 2025-03-31 NI056317 uk-bus:Director4 4 2026-03-31 NI056317 uk-bus:Director5 5 2025-04-01 2026-03-31 NI056317 uk-bus:Director5 5 2025-03-31 NI056317 uk-bus:Director5 5 2026-03-31 NI056317 uk-bus:Director6 6 2025-04-01 2026-03-31 NI056317 uk-bus:Director6 6 2025-03-31 NI056317 uk-bus:Director6 6 2026-03-31 NI056317 uk-bus:Director7 7 2025-04-01 2026-03-31 NI056317 uk-bus:Director7 7 2025-03-31 NI056317 uk-bus:Director7 7 2026-03-31 NI056317 uk-bus:Director8 8 2025-04-01 2026-03-31 NI056317 uk-bus:Director8 8 2025-03-31 NI056317 uk-bus:Director8 8 2026-03-31 NI056317 uk-bus:Director9 9 2025-04-01 2026-03-31 NI056317 uk-bus:Director9 9 2025-03-31 NI056317 uk-bus:Director9 9 2026-03-31 NI056317 uk-bus:Director10 10 2025-04-01 2026-03-31 NI056317 uk-bus:Director10 10 2025-03-31 NI056317 uk-bus:Director10 10 2026-03-31 NI056317 uk-bus:Director11 11 2025-04-01 2026-03-31 NI056317 uk-bus:Director11 11 2025-03-31 NI056317 uk-bus:Director11 11 2026-03-31 NI056317 uk-bus:Director12 12 2025-04-01 2026-03-31 NI056317 uk-bus:Director12 12 2025-03-31 NI056317 uk-bus:Director12 12 2026-03-31 NI056317 uk-bus:Director13 13 2025-04-01 2026-03-31 NI056317 uk-bus:Director13 13 2025-03-31 NI056317 uk-bus:Director13 13 2026-03-31 NI056317 uk-bus:Director14 14 2025-04-01 2026-03-31 NI056317 uk-bus:Director14 14 2025-03-31 NI056317 uk-bus:Director14 14 2026-03-31 NI056317 uk-bus:Director15 15 2025-04-01 2026-03-31 NI056317 uk-bus:Director15 15 2025-03-31 NI056317 uk-bus:Director15 15 2026-03-31 NI056317 uk-bus:Director16 16 2025-04-01 2026-03-31 NI056317 uk-bus:Director16 16 2025-03-31 NI056317 uk-bus:Director16 16 2026-03-31 NI056317 uk-bus:Director17 17 2025-04-01 2026-03-31 NI056317 uk-bus:Director17 17 2025-03-31 NI056317 uk-bus:Director17 17 2026-03-31 NI056317 uk-bus:Director18 18 2025-04-01 2026-03-31 NI056317 uk-bus:Director18 18 2025-03-31 NI056317 uk-bus:Director18 18 2026-03-31 NI056317 uk-bus:Director19 19 2025-04-01 2026-03-31 NI056317 uk-bus:Director19 19 2025-03-31 NI056317 uk-bus:Director19 19 2026-03-31 NI056317 uk-bus:Director20 20 2025-04-01 2026-03-31 NI056317 uk-bus:Director20 20 2025-03-31 NI056317 uk-bus:Director20 20 2026-03-31 NI056317 1 2025-04-01 2026-03-31 NI056317 2 2025-04-01 2026-03-31 NI056317 3 2025-04-01 2026-03-31

# HORNER PHARMACY LIMITED

## Company Registration Number:
NI056317 (Northern Ireland)

## Unaudited abridged accounts for the year ended 31 March 2026

## Period of accounts

## Start date: 01 April 2025

## End date: 31 March 2026

# HORNER PHARMACY LIMITED

## Contents of the Financial Statements

for the Period Ended 31 March 2026

Balance sheet |
Notes |

# HORNER PHARMACY LIMITED

## Balance sheet

As at 31 March 2026

| Notes | 2026 | 2025
--- | --- | --- | ---
|  | £ | £
Fixed assets
Tangible assets: | 3 | 236,066 | 230,716
Total fixed assets: |  | 236,066 | 230,716
Current assets
Stocks: |  | 297,604 | 286,158
Debtors: | 4 | 357,389 | 293,051
Cash at bank and in hand: |  | 218,816 | 189,265
Total current assets: |  | 873,809 | 768,474
Creditors: amounts falling due within one year: | 5 | (427,338) | (400,926)
Net current assets (liabilities): |  | 446,471 | 367,548
Total assets less current liabilities: |  | 682,537 | 598,264
Creditors: amounts falling due after more than one year: | 6 | (25,575) | (53,475)
Provision for liabilities: |  | (34,959) | (35,129)
Total net assets (liabilities): |  | 622,003 | 509,660
Capital and reserves
Called up share capital: |  | 100 | 100
Profit and loss account: |  | 621,903 | 509,560
Shareholders funds: |  | 622,003 | 509,660

The notes form part of these financial statements

# HORNER PHARMACY LIMITED

## Balance sheet statements

For the year ending 31 March 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 09 July 2026
and signed on behalf of the board by:

Name: Mr John Horner
Status: Director

The notes form part of these financial statements

# HORNER PHARMACY LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2026

## 1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

# HORNER PHARMACY LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2026

## 2. Employees

| 2026 | 2025
--- | --- | ---
Average number of employees during the period | 24 | 29

# HORNER PHARMACY LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2026

## 3. Tangible Assets

| Total
--- | ---
Cost | £
At 01 April 2025 | 1,092,560
Additions | 67,909
At 31 March 2026 | 1,160,469
Depreciation |
At 01 April 2025 | 861,844
Charge for year | 62,559
At 31 March 2026 | 924,403
Net book value |
At 31 March 2026 | 236,066
At 31 March 2025 | 230,716

# HORNER PHARMACY LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2026

## 4. Debtors

| 2026 | 2025
--- | --- | ---
| £ | £
Debtors due after more than one year: | 0 | 0

# HORNER PHARMACY LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2026

## 5. Creditors: amounts falling due within one year note

Trade creditors £332,699 Accruals £12,834 Corporation tax £53,905 Obligations under finance lease £27,900

# HORNER PHARMACY LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2026

## 6. Creditors: amounts falling due after more than one year note

Obligations under finance leases £25,575

# HORNER PHARMACY LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2026

## 7. Related party transactions

Name of the related party: |
Relationship: | Director
Description of the Transaction: | The company occupies premises owned by the director Mr John Horner to whom a commercial rent of £40,000 is payable annually. At 31/3/26 Horner Pharmacy Ltd owed the directors, Mr John Horner and Mrs Myrna Horner £0.
£
Balance at 01 April 2025 |  | 68,540
Balance at 31 March 2026 |  | 0